Global /China /Healthcare /Drug Manufacturers - General /603676

Tibet Weixinkang Medicine Co., Ltd.

603676

• SSE: 603676 • Delayed

10.60CNY 0%

1.57 USD

As of 18 June 2026, Tibet Weixinkang Medicine Co., Ltd. has a market cap of $678.1M USD, ranking #13166 globally and #3972 in China. It ranks #1191 in the Healthcare sector, and #439 in the Drug Manufacturers - General industry.

Global Rank

13166

Country Rank

3972

Sector Rank

1191

Industry Rank

439

Key Stats

Market Cap

$678.1MUSD

4.58B CNY

Enterprise Value

$524.16MUSD

3.54B CNY

Revenue (TTM)

$171.95MUSD

1.16B CNY

EBITDA (TTM)

$43.44MUSD

293.56M CNY

Net Income (TTM)

$32.06MUSD

216.65M CNY

EBITDA Margin

25%

Profit Margin

19%

PE Ratio

21.2

PS Ratio

3.9

PB Ratio

3.0

EV/EBITDA

11.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yong Zhang open_in_new

Employees

689

Founded

2002

Website

wxkpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	2.7%	0.6%	-5.2%	-10%	0.8%	0.8%	-29%	16%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603676 西藏卫信康医药股份有限公司 Class A ISIN: CNE100002QQ3 Shares Out.: Shares Outstanding: 432.334M¹ Shares Float: 137.746M² TV: TradingView: SSE: 603676 SA: Stock Analysis: SHA: 603676 YF: Yahoo Finance: 603676.SS GF: Google Finance: SHA: 603676 BA: Barron's: 603676 MS: Morningstar: XSHG: 603676	10.60 CNY	TV: TradingView: SSE: 603676 SA: Stock Analysis: SHA: 603676 YF: Yahoo Finance: 603676.SS GF: Google Finance: SHA: 603676 BA: Barron's: 603676 MS: Morningstar: XSHG: 603676

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tibet Weixinkang Medicine Co., Ltd.

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins; electrolyte supplements; intravenous iron, trace, electrolytes, and amino acids supplements; antibiotics; acetylcysteine solution for inhalation; medicine for liver diseases; and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2002 and is based in Lhasa, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.99B 364.89B CNY 8K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.77B 336.36B CNY 7K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 112K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 81K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 53K%	97.4	United States
Roche Holding AG SIX: RO	$321.45B 256.25B CHF 47K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.52B 215.59B GBP 42K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.59B 218.9B CHF 40K%	20.5	Switzerland

chevron_leftBack